Boundless Bio, Inc.
BOLD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001782303
In the last 90 days, Boundless Bio, Inc. insiders filed 4 open-market purchases and 2 sales; 40 institutions reported holding it in 13F filings for Q2 2026, worth $38.3M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Boundless Bio, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 44 | 35 | −9 |
| Shares | 9.79M | 9.62M | −166.0K (−1.7%) |
| Value | $9.88M | $11.8M | +$1.95M (+19.7%) |
New holders (1)
Institutions that held Boundless Bio, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Optiver Holding B.V. | 168 | $207 | 0.00% |
Sold out (10)
Institutions that held Boundless Bio, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Y-Intercept (Hong Kong) Ltd | 55,242 | $55.8K |
| Susquehanna International Group, LLP | 32,211 | $32.5K |
| HRT Financial LP | 27,509 | $27.0K |
| Wells Fargo & Company | 2,582 | $2.61K |
| Citigroup Inc | 2,551 | $2.58K |
| JPMorgan Chase & Co | 1,127 | $1.14K |
| Raymond James Financial Inc | 1,000 | $1.01K |
| Clearstead Advisors, LLC | 24 | $25 |
| EverSource Wealth Advisors, LLC | 2 | $2 |
| Royal Bank of Canada | 97 | $0 |